Finance

Lists
603538:SHA
Ningbo Menovo Pharmaceutical Co Ltd
CNÂ¥28.07
+2.22%
(+0.61) 1D
Sep 8, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603538...
Open
CNÂ¥27.51
High
CNÂ¥28.21
Low
CNÂ¥26.99
Mkt. cap
9.29B
Avg. vol.
57.58M
Volume
47.25M
Dividend
0.39%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
79.26
52-wk high
CNÂ¥50.28
52-wk low
CNÂ¥13.55
EPS
CNÂ¥0.35
Shares outstanding
149.13M
No. of employees
2K
Open
CNÂ¥27.51
High
CNÂ¥28.21
Low
CNÂ¥26.99
Mkt. cap
9.29B
Avg. vol.
57.58M
Volume
47.25M
Dividend
0.39%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jul 9, 2026
P/E ratio
79.26
52-wk high
CNÂ¥50.28
52-wk low
CNÂ¥13.55
EPS
CNÂ¥0.35
Shares outstanding
149.13M
No. of employees
2K
About Ningbo Menovo Pharmaceutical Co Ltd
CEO-
Employees2.37K
FoundedFeb 19, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
439.46M
386.33M
337.65M
521.17M
Cost of goods sold
290.04M
264.93M
246.07M
358.46M
Cost of revenue
290.04M
264.93M
246.07M
358.46M
Research and development expenses
24.18M
45.05M
9.59M
29.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.14M
59.07M
43.79M
52.68M
Operating expense
69.40M
122.37M
47.60M
93.06M
Total operating expenses
359.45M
387.30M
293.67M
451.52M
Operating income
80.02M
-974.95K
43.98M
69.65M
Other non operating income
-1.09M
-4.04M
-9.70M
6.71M
EBT including unusual items
57.88M
11.60M
37.14M
53.22M
EBT excluding unusual items
71.14M
-14.36M
35.96M
61.02M
Income tax expense
9.83M
6.62M
4.67M
20.10M
Effective tax rate
16.98%
57.06%
12.57%
37.77%
Other operating expenses
-10.84M
14.54M
-3.13M
4.72M
Net income
46.87M
6.30M
31.16M
32.53M
Net profit margin
10.67%
1.63%
9.23%
6.24%
Earnings per share
-
-
-
-
Interest and investment income
3.30M
-
12.36M
3.20M
Interest expense
-10.14M
-5.68M
-10.67M
-1.88M
Net interest expenses
-6.84M
-5.68M
1.68M
1.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
112.41M
32.08M
77.03M
104.33M
Gain or loss from assets sale
-1.90M
142.66K
-
1.02M
AI content may include mistakes. Learn more
Google apps